Whittier Trust Co. of Nevada Inc. Has $11.39 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 157.3% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 23,180 shares of the medical equipment provider’s stock after purchasing an additional 14,172 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in Intuitive Surgical were worth $11,387,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the stock. Mirador Capital Partners LP grew its stake in shares of Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after buying an additional 50 shares in the last quarter. Advisors Asset Management Inc. increased its stake in shares of Intuitive Surgical by 18.1% during the 1st quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock worth $2,945,000 after purchasing an additional 1,129 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of Intuitive Surgical by 617.1% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after purchasing an additional 76,649 shares during the period. Brookstone Capital Management lifted its stake in Intuitive Surgical by 22.4% in the 2nd quarter. Brookstone Capital Management now owns 12,530 shares of the medical equipment provider’s stock valued at $5,340,000 after purchasing an additional 2,289 shares during the last quarter. Finally, M&G Plc grew its holdings in Intuitive Surgical by 53.5% during the second quarter. M&G Plc now owns 5,069 shares of the medical equipment provider’s stock worth $2,256,000 after purchasing an additional 1,766 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday. Wells Fargo & Company raised their price target on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a report on Friday. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday. Piper Sandler restated an “overweight” rating and set a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday. Finally, Morgan Stanley upped their price target on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $513.74.

Read Our Latest Report on ISRG

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 450 shares of Intuitive Surgical stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the transaction, the director now owns 821 shares in the company, valued at $402,519.88. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, Director Amy L. Ladd sold 450 shares of the company’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the transaction, the director now directly owns 821 shares in the company, valued at approximately $402,519.88. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Mark Brosius sold 2,115 shares of the stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total value of $1,040,389.65. Following the completion of the transaction, the insider now owns 295 shares of the company’s stock, valued at $145,113.45. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 53,120 shares of company stock valued at $25,528,753. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded down $1.02 on Monday, reaching $520.13. 874,800 shares of the stock were exchanged, compared to its average volume of 1,475,606. The firm’s 50 day moving average is $483.85 and its 200-day moving average is $438.56. The firm has a market cap of $184.49 billion, a PE ratio of 94.07, a P/E/G ratio of 5.40 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $523.34.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last issued its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. During the same quarter last year, the business posted $1.18 EPS. The company’s revenue was up 14.5% compared to the same quarter last year. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.